Pseudodementia

Pseudodementia is a syndrome of cognitive impairment caused by underlying psychiatric illness, most commonly major depressive disorder, that closely mimics organic dementia in clinical presentation but is reversible with effective treatment of the underlying psychiatric condition. The term was popularized by Wells (1979) and remains controversial as some experts argue it should be replaced with terms like 'depression-induced cognitive impairment' or 'reversible dementia syndrome of depression' since the cognitive impairment is genuine, not feigned. Pseudodementia is most common in elderly patients with severe depression, where the dual concerns of dementia and depression complicate diagnosis. Clinically significant prevalence: approximately 10-20% of elderly patients presenting with apparent cognitive impairment have an underlying depressive component significantly contributing to the cognitive presentation.

Distinguishing features between pseudodementia and true dementia (though overlap and atypical presentations occur in both): pseudodementia tends to have abrupt onset (over weeks), patient awareness and concern about cognitive deficits (often emphasizing them spontaneously), 'don't know' responses common, history of psychiatric illness or recent psychosocial stressors, prominent depressive symptoms (sadness, anhedonia, vegetative symptoms, suicidal ideation), preserved orientation in early stages, variable test performance with effort dependence, normal language and visuospatial skills, equal performance on memory tests for recent and remote events, improvement with treatment of depression. True organic dementia (especially Alzheimer's) tends to have insidious gradual onset, patient unawareness or denial of deficits, near-miss responses (confabulation), no significant psychiatric history initially, less prominent mood symptoms, disorientation in time and place early, consistently impaired test performance, language difficulties (anomia, paraphasia), constructional apraxia, more impaired memory for recent than remote events, persistent or progressive cognitive decline despite intervention.

Diagnostic evaluation requires comprehensive assessment: detailed history including onset, course, psychiatric history, medications, alcohol use, comprehensive cognitive testing (Mini-Mental State Examination, Montreal Cognitive Assessment, neuropsychological testing), depression assessment (Geriatric Depression Scale, PHQ-9, Hamilton Depression Rating Scale), laboratory workup to exclude metabolic causes (TSH, B12, electrolytes, liver/kidney function), brain imaging (MRI preferred — looking for vascular changes, atrophy patterns, hippocampal volume), structured psychiatric evaluation. Treatment of underlying depression: antidepressants (SSRIs first-line in elderly — sertraline, citalopram, escitalopram preferred for tolerability; SNRIs as alternative; avoid tricyclics due to anticholinergic effects), psychotherapy (cognitive-behavioral, problem-solving, interpersonal therapy), electroconvulsive therapy (ECT) for severe, treatment-resistant, or psychotic depression — particularly effective in elderly with melancholic features. Cognitive symptoms should improve with depression treatment over weeks to months. Recent longitudinal studies show concerning finding: pseudodementia may not be entirely 'pseudo' — 20-50% of patients diagnosed with pseudodementia develop true neurodegenerative dementia within 3-5 years, suggesting depression in elderly may be a prodromal phase or risk factor for dementia, or that subtle dementia coexists with depression. Implications: vigilant follow-up after depression treatment, repeat cognitive assessment if cognitive symptoms persist or progress, consideration of comorbid depression and early dementia, importance of treating depression aggressively while monitoring for emerging dementia. Differential diagnosis: vascular cognitive impairment, mild cognitive impairment, normal pressure hydrocephalus, medication effects (anticholinergic burden), sleep disorders, delirium, hypothyroidism, B12 deficiency, neurosyphilis, substance use, malingering (rare).